Cite
HARVARD Citation
Aranda, E. et al. (2018). First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study. European journal of cancer. pp. 263-272. [Online].